VOICES IN UROLOGY
 
ABU makes changes to reduce burden during pandemic
"During these times of uncertainty, panic, and social distancing associated with COVID-19, the American Board of Urology is sensitive to the additional stress this pandemic has placed on urology practices and urologists’ ability to meet their certificate requirements," writes J. Brantley Thrasher, MD.
Learn more
 
An end to the decline in prostate cancer mortality
"The recently reported change in PCa death rates should prompt men to undergo genetic testing and have a discussion with their doctor regarding the benefits and potential harms of PSA-based screening based on their individualized risk of developing the disease," write Franklin Gaylis, MD, and A. Karim Kader, MD, PhD.
Read their op-ed
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
 
MORE FROM UROLOGY TIMES
 
Urology and precision medicine in the COVID-19 era
Dealing with COVID-19: Readers weigh in
 
JOB OPPORTUNITIES